ReviewCancers2021

Cyclin-Dependent Kinase Inhibitors in Hematological Malignancies-Current Understanding, (Pre-)Clinical Application and Promising Approaches.

Anna Richter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.